Vuong Trieu, CHAIRMAN AND CEO, 10% Owner at Oncotelic Therapeutics, Inc. (OTLC), bought 400,000 shares at $0.03 ($12K) on 2023-06-14, disclosed to the SEC on 2023-06-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| OTLC | BUY | 2026-06-17 | $15K | — | Filing → |
| OTLC | BUY | 2025-07-10 | $2K | — | Filing → |
| OTLC | BUY | 2025-01-31 | $10K | — | Filing → |